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ABSTRACT
Expression of cyclooxygenase-2 (COX-2) and prostaglandin E2
(PGE2) receptor 2 (EP2) are necessary for rodent cumulus ex-
pansion in vivo. Prostaglandin E2 receptor 3 (EP3) has been de-
tected in bovine preovulatory follicles and corpora lutea. The
current experiments examined the effect of PGE2 on bovine cu-
mulus expansion in vitro and expression of COX-2, EP1, EP2,
EP3, and EP4 mRNAs in bovine cumulus-oocyte complexes
(COCs) at 0, 6, 12, 18, and 24 h time points during maturation
in vitro. Concentrations of PGE2 above 50 ng/ml resulted in
moderate cumulus expansion of bovine COCs, but expansion did
not occur in the absence of serum. COX-2 mRNA expression
increased in bovine COCs at 6 h and 12 h of maturation, then
decreased. EP2 mRNA was detectable by reverse transcription-
polymerase chain reaction at all time points. EP3 mRNA ex-
pression increased in COCs from 0 to 6 h and remained at this
higher level through the culture period. Very low levels of EP4
mRNA expression were detectable, but EP1 was not detected in
bovine COCs. Because EP receptor mRNAs and COX-2 mRNA
are expressed in bovine COCs, there exists the potential for a
prostaglandin autocrine/paracrine regulatory pathway during
oocyte maturation. Differential expression of the EP3 mRNA
among varying COC classes indicates that this gene product may
be a useful marker of oocyte competence. Although the PGE2
pathway is involved in cumulus expansion, serum factors are
required to mediate PGE2-induced expansion.
cumulus cells, gene regulation, in vitro fertilization, oocyte de-
velopment, ovary
INTRODUCTION
Early experiments have shown a role for prostaglandin
E2 (PGE2) in cumulus expansion in vitro in mice [1] and
rats [2]. There are two isoforms of an enzyme known to
control the prostaglandin synthesis pathway: the constitu-
tively active cyclooxygenase-1 (COX-1) and the inducible
cyclooxygenase-2 (COX-2) [3, 4]. Although both COX-1
and COX-2 mRNAs are expressed in the uterus during the
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time of implantation [5], COX-1 knockouts display normal
fertility but have difficulties in parturition [6], while COX-
2 knockouts have defects in ovulation, fertilization, deci-
dualization, and implantation [7]. In rodents, COX-2 pro-
tein is first detected in the granulosa of eCG-induced pre-
ovulatory follicles following hCG treatment [8, 9]. In cattle,
COX-2 protein is expressed in the granulosa of some pre-
ovulatory follicles by 18 h after hCG, and more preovula-
tory follicles express COX-2 protein by 24 h [10]. COX-1
protein is not induced by hCG in bovine preovulatory fol-
licles [11]. Thus, the COX-2 isoform is more likely than
the COX-1 isoform to have an important role in early re-
productive events in cattle, including oocyte maturation,
ovulation, and fertilization.
Prostaglandin E2 concentrations are very low in bovine
follicular fluid before the gonadotropin surge and remain
low at 18 h but increase to 13 ng/ml in preovulatory fol-
licles 24 h after hCG [10]. Systemic treatment with PGE2
restores the ability of COX-2 knockout mice to ovulate [9].
A small amount of PGE2 is synthesized by maturing bovine
cumulus-oocyte complexes (COCs) in vitro [12, 13]. How-
ever, the predominant source of intrafollicular PGE2 is
granulosa cells [14]. Although murine granulosa cells se-
crete sufficient PGE2 to induce cumulus expansion, cumuli
will not expand in the absence of serum [14]. Serum factors
are required for hyaluronic acid retention within the ex-
panding cumulus [1, 15, 16]. In recent years, this serum
factor was determined to be of the inter-a-inhibitor family
(IaI) [16, 17].
Prostaglandin E2 receptors are members of the G-type
receptor family; there are currently four subtypes (EP1–
EP4) known that activate different and often conflicting
pathways. Activation of EP1 and EP3 generally results in
contraction of smooth muscle, while activation of EP2 and
EP4 receptors generally results in relaxation; activation of
EP2 and EP4 receptors increase cAMP, EP1 increases Ca21
mobilization, EP3A decreases cAMP, EP3B and C isoforms
increase cAMP, and EP3D increases Ca21 [18]. EP2 has
recently been detected in the mouse cumulus [19], targeted
deletions for EP2 have been generated by three groups, and
all null mouse lines have defects in ovulation and fertiliza-
tion [19–21] with one strain displaying defects in cumulus
expansion [19]. In addition, another PGE receptor mRNA
(EP3) has been recently detected in bovine and ovine pre-
ovulatory follicles and corpora lutea [22, 23].
For over 20 yr, research has focused on the induction of
bovine oocyte maturation in vitro. However, with even the
best systems developed thus far, including maturation in
TCM-199 (tissue culture media) containing serum, gonad-
otropins, and estradiol at 38.58C in 5% CO2 in air, and
embryo culture in TCM-199 or cSOFMaa (citrate supple-
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TABLE 1. Primers for COX-2 and bovine prostaglandin E2 receptors.
Product 59 39
Temperature
(8C)
Size
(bp)
COX-2
EP1
EP2
EP3
EP4
GCCTGGTCTGATGATGTATGC
CCAGCTCGTAGGCATCATGG
CCTGCAACTTCAGCGTCAT
CAAGCCACATGAAGACCAGC
CAAGGAGCAGAAGGAGACGA
GGTGAGGTGCGTATCTTGAAC
CTTGAAGGCAGCAGGCGAAC
TCTAAGAGCTTGGAGGTCCC
TCATTATCAGCAACGGCGAC
GGCTGTAGAAGTAGGCGTGG
54
57
54
58
57
880
216
251
408
248
mented synthetic oviductal fluid media with amino acids)
in a reduced O2 gas atmosphere; only 30%–35% of im-
mature COCs collected develop to the blastocyst stage [24,
25]. Therefore, the purpose of these experiments was to
investigate the role of PGE2 and serum factors in inducing
bovine cumulus expansion in vitro. In addition, expression
of COX-2, EP1, EP2, EP3, and EP4 mRNAs was examined
in bovine COCs of differing qualities during maturation in
vitro.
MATERIALS AND METHODS
Bovine COCs were isolated by follicular aspiration using an 18-gauge
needle connected to a vacuum system from slaughterhouse ovaries pro-
vided by ABEL Laboratories (Guelph, ON, Canada). Serum-free TCM-
199 (Gibco BRL, Burlington, ON, Canada), buffered with Hepes and bi-
carbonate, with 50 IU/ml heparin (Leo Pharma, Ajax, ON, Canada) was
used for washing COCs. Pools of 35–65 COCs were matured in vitro in
0.5 ml TCM-199 containing bicarbonate and pyruvate in four-well plates
(Nalge Nunc International, Roskilde, Denmark) at 38.58C in a 5% CO2 in
air atmosphere. There were seven replicates with a total of about 400
COCs/treatment. Serum (newborn calf serum) was obtained from Gibco
BRL. PGE2 (Cayman Chemical, Ann Arbor, MI) was dissolved in 100%
ethanol to produce a stock solution of 100 ng/ml. COCs were evaluated
for cumulus expansion at 21–22 h of maturation as I, little to no expansion;
II, moderate expansion; and III, full expansion [26].
For analysis of COX-2, EP1, EP2, EP3, and EP4 mRNAs, COCs were
matured in TCM-199 containing pyruvate, pFSH (1 mg/ml FSH; Vetre-
pharm, Ottawa, ON, Canada), oLH (5 mg/ml LH; Vetrepharm), estradiol-
17b (1 mg/ml estradiol-17b; Sigma-Aldrich, Oakville, ON, Canada), and
10% serum. COCs were divided into three quality grades prior to place-
ment in maturation media, similar to previous reports [27, 28]. Quality
grade one consisted of COCs with even oocyte granulation and multiple
layers of cumulus cells, quality grade two COCs had uneven granulation
of the oocyte or only one or two layers of cumulus cells, while quality
grade three COCs had several defects: small oocyte, very uneven granu-
lation of oocyte, cumulus already expanded or incomplete or absent cu-
mulus cell layers. In previous experiments, small oocytes have been re-
ported to be incompetent to complete meiosis [29], and in other experi-
ments, developmental rates have been reported to be lower with poorer
quality oocytes [28], thus this group may be expected to have altered
mRNA expression levels. The experiment was replicated four times. Ali-
quots of COCs (50) of each quality grade were removed and placed into
0.5-ml microcentrifuge tubes at 0 h (following final wash) or 6, 12, 18,
or 24 h after dishes were placed into the incubator for maturation. Excess
medium was removed after brief centrifugation, and COCs were frozen in
liquid nitrogen before being transferred to a 2708C freezer. Total RNA
was extracted from COCs with 24 mg Escherichia coli rRNA (Roche Mo-
lecular Biochemicals, Laval, PQ, Canada) as a carrier, by using a standard
phenol/chloroform extraction method [30]. The RNA samples were quan-
tified by measuring 260/280 nm OD absorbance using spectrophotometry.
For analysis of COX-2, EP2, EP3, and EP4 expression, RNA samples
representing 40 COC equivalents were reverse transcribed as reported pre-
viously [31] with oligo (dT)12–18 primer (Gibco BRL) and Superscript
(Gibco BRL), except the volume was doubled to 40 ml (1 COC/ml). Just
prior to reverse transcription, 0.1 pg rabbit globin mRNA (Gibco BRL)
was added per COC equivalent [31]. For EP1, RNA samples were reverse
transcribed using random hexamers (2 ml/20 ml reaction; Boehringer-
Mannheim, Germany). RNA from positive control bovine tissues (liver for
b-actin, kidney for COX-2 and EP2, lung for EP4, corpus luteum for EP3)
was extracted using a standard phenol/chloroform technique, and 1–2.5
mg of RNA was reverse transcribed as above. For EP1, kidney was reverse
transcribed with random hexamers.
The b-actin primers were as reported previously [31]. These primers
amplify a 243-base pair (bp) product at an annealing temperature of 568C
for 37 cycles and, because they are intron-spanning, were used to detect
possible genomic contamination (408-bp product). The a-globin primers
were as reported previously [31] and amplified a product of 257 bp at
558C for 30 cycles. Primers for COX-2 and EP1–EP4 are in Table 1.
Bovine primers for COX-2 were designed from the published sequence
(Genbank accession number AF031698). The primers amplified a product
of 880 bp at 548C. EP1 primers were designed from a partial ovine se-
quence (Genbank accession number AF035415) [32], and these primers
amplified a product of the expected size of 216 bp from kidney at 578C
for 45 cycles; however, a product was never amplified from COCs despite
variations made in MgCl2, cycle number, and temperature. The EP2 prim-
ers were designed to amplify a conserved region of EP2 mRNA by run-
ning a sequence comparison of rat, mouse, human, ovine, and canine se-
quences (Genbank accession numbers U48858, D50589, U19487,
AF035416, and AF075602). Primers amplified a product of 251 bp at
548C. Sequences for bovine EP3 [33] (Genbank accession numbers
D21345, D21346, D21347, D21348) were known and primers were de-
signed from these sequences. The EP3 primers amplified a single product
of 408 bp (common to all isoforms) at 588C. EP4 primers were designed
from a partial ovine sequence (Genbank accession number AF035418)
[32]. The EP4 primers amplified a product of 248 bp at 578C for 40 cycles.
All primers were synthesized by Gibco BRL. The identity of the COX-2,
EP2, EP3, and EP4 products was confirmed by dye-deoxysequencing (Ro-
barts Research Institute, London, ON, Canada).
COX-2, EP2, and EP3 mRNAs were subjected to reverse transcription-
polymerase chain reaction (RT-PCR) and agarose gel electrophoresis.
Bands were quantified by comparing the ratio of band intensity to the a-
globin standard [31, 34]. EP4 mRNAs were not quantified due to low
abundance. Two microliters of cDNA (two COC equivalents) was added
to each PCR reaction; for positive control tissues, 1–2 ml cDNA was added
per tube. PCRs were carried out with 103 PE Gold buffer (Perkin-Elmer,
Canada Ltd., Mississauga, ON, Canada) with a final concentration of 1.25–
2 mM MgCl2 (Perkin Elmer), primer concentration 1 mM (2 mM for actin),
200 mM dNTPs (Gibco-BRL), and 1 unit AmpliTaq Gold DNA Polymer-
ase (Perkin-Elmer). The basic program included a soak of 958C for 10
min, followed by a cycle program of 958C for 1 min, gene-specific an-
nealing temperature for 30 sec, and 728C for 1 min, followed by a final
extension at 728C for 10 min. The numbers of cycles required to achieve
amplification in the linear range were tested in a preliminary experiment.
All PCR reactions were done in Perkin-Elmer GeneAmp 2400 thermo-
cyclers (PE Applied Biosystems, Mississauga, ON, Canada). Twenty mi-
croliters of product was resolved on a 2% agarose gel containing ethidium
bromide and a Gene-Ruler 100-bp DNA ladder (MBI Fermentas Inc.,
Flamborough, ON, Canada). Photographs were taken with a UV camera
system (Amersham Pharmacia Biotech, Baie d’Urfe, PQ, Canada). Image
analysis and quantification was done with the ImageMaster VDS program
(Amersham Pharmacia Biotech).
Statistical Analyses
For studying the effects of PGE2 on expansion, x2 tests were performed
according to the method of Snedecor [35]. For gene expression, multiple
ANOVA was performed using the Practical Statistics program (Canadian
Academic Technology Inc., West Flamborough, ON, Canada) with main
effects of quality grade and time of maturation. There was no interaction
between grade and time effects. Where significant main effects existed,
mean separation procedures were performed to detect differences.
RESULTS
Effect of PGE2 on Bovine Cumulus Expansion
An experiment was carried out to determine whether, in
agreement with rodent data, PGE2 has an effect on expan-
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FIG. 1. Percent cumulus expansion of bovine COCs matured 24 h in
vitro with varying doses of PGE2 (ng/ml) with and without 10% serum
compared to positive control COCs matured in TCM-199 containing 10%
serum and 1 mg/ml FSH, 5 mg/ml LH, and 1 mg/ml estradiol-17b. I is no
expansion, II is moderate expansion, III is full expansion. x2 tests were
performed to determine differences in the percentage of COCs that un-
derwent partial or full expansion (II or III). a–dValues with no superscripts
in common are different at P , 0.05.
FIG. 3. Expression of COX-2 mRNA in three quality grades of bovine
COCs during maturation in vitro. Solid bars: Expression in quality grade
1 COCs at 0, 6, 12, 18, and 24 h, respectively. Hatched bars: Expression
in quality grade 2 COCs at 0, 6, 12, 18, and 24 h, respectively. White
bars: Expression in quality grade 3 COCs at 0, 6, 12, 18, and 24 h, re-
spectively. Mean 6 SEM (n 5 4 replicates). w–zTime points with no su-
perscripts in common are different at P , 0.05.
FIG. 4. Partial sequence of bovine EP2. The PCR-amplified product has
97% homology at the nucleotide level to the partial ovine EP2 sequence
(AF035416). Bovine sequence is on top, ovine on the bottom. Dashes
indicate identical bases; gaps indicate nucleotide differences from the
ovine sequence.
FIG. 2. Representative RT-PCR figures with gene on the left and PCR
product size in bp on right. The leftmost lane is the 100-bp DNA marker
lane followed by oocyte quality 1, hour 0; quality 1, hour 6, etc. The (2)
lane is the PCR blank that contains all components except cDNA. This is
followed by another marker lane and then a (1) positive tissue control
lane.
sion of bovine COCs in vitro. A dose-dependent effect of
PGE2 was seen on bovine cumulus expansion in the pres-
ence of 10% serum. Doses of PGE2 above 50 ng/ml con-
sistently increased expansion of bovine COCs (Fig. 1).
However, COCs matured with the highest PGE2 dose test-
ed, 500 ng/ml, did not achieve expansion equivalent to that
of COCs matured in media containing serum and gonado-
tropins. Bovine COCs did not expand when cultured with
500 ng/ml PGE2 in the absence of serum.
Effect of COC Quality and Maturation on Expression
of COX-2, EP2, and EP3 mRNAs
Because PGE2 was shown to induce cumulus expansion,
it was necessary to determine whether COX-2 mRNA, an
enzyme required for synthesis of PGE2, was present in the
cumulus cells, which could indicate an autocrine action. In
addition, it was important to determine which PGE2 recep-
tor mRNAs were present and could be involved in signaling
in the bovine COC and the time course of expression during
in vitro maturation. Representative pictures of PCR-ampli-
fied products are shown in Figure 2. Weak expression of
COX-2 mRNA was detected by RT-PCR in bovine COCs
of all COC quality grades at 0 h (Fig. 3), prior to initiation
of maturation. There was no effect of COC quality grade
on expression of COX-2 mRNA. However, there was an
overall effect of maturation time (P , 0.002), with in-
creased expression at 6–12 h of maturation compared to 0
h (P , 0.002, Fig. 3). Expression decreased and was again
lower at 24 h than at 6 and 12 h (P , 0.02). Increased
COX-2 mRNA expression was apparent in COCs at 6 h,
which was prior to morphological evidence of cumulus ex-
pansion (12 h).
The partial sequence of bovine EP2 is reported in Figure
4. EP2 mRNA was detected by RT-PCR in bovine COCs
of all quality grades at 0 h of oocyte maturation (Fig. 5).
There were no differences among COC quality grades, but
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FIG. 5. Expression of EP2 mRNA in three quality grades of bovine COCs
during maturation in vitro. Solid bars: Expression in quality grade 1 COCs
at 0, 6, 12, 18, and 24 h, respectively. Hatched bars: Expression in quality
grade 2 COCs at 0, 6, 12, 18, and 24 h, respectively. White bars: Ex-
pression in quality grade 3 COCs at 0, 6, 12, 18, and 24 h, respectively.
Mean 6 SEM (n 5 4 replicates).
FIG. 6. Expression of EP3 mRNA in three quality grades of bovine COCs
during maturation in vitro. Solid bars: Expression in quality grade 1 COCs
at 0, 6, 12, 18, and 24 h, respectively. Hatched bars: Expression in quality
grade 2 COCs at 0, 6, 12, 18, and 24 h, respectively. White bars: Ex-
pression in quality grade 3 COCs at 0, 6, 12, 18, and 24 h, respectively.
Mean 6 SEM (n 5 4 replicates). abCOC quality grades with no superscripts
in common are different, at least P , 0.05. x–zTime points with no su-
perscripts in common are different, at least P , 0.05.
FIG. 7. A partial sequence of bovine EP4. The PCR-amplified product
has 94% homology at the nucleotide level to the partial ovine EP4 se-
quence (AF035418). The bovine sequence is on top, ovine on the bottom.
Dashes indicate identical bases, gaps indicate nucleotide differences from
the ovine sequence.
there was an overall trend (P , 0.07) toward decreased
expression throughout the maturation period.
There was an overall effect of COC quality grade on
abundance of EP3 mRNA (Fig. 6). Higher expression of
EP3 mRNA was detected in COC quality grades 1 and 2
than in quality grade 3 COCs (P , 0.003 and P , 0.05,
respectively). There was an overall effect of maturation
time on abundance of EP3 mRNA (P , 0.003). Expression
of EP3 mRNA was lowest at 0 h but increased and re-
mained elevated from 6 to 24 h of maturation (all at least
P , 0.02). The partial sequence of bovine EP4 is reported
in Figure 7. EP4 was detected inconsistently at low levels
in bovine COCs (data not shown).
DISCUSSION
Doses of 100 ng/ml PGE2 caused maximal expansion of
mouse COCs in vitro in the presence of serum [1]. It is
reported that preovulatory bovine follicular fluid concentra-
tions of PGE2 increase to 13 ng/ml after hCG [10] or 88
ng/ml 20 h after an endogenous LH surge [36]. A signifi-
cant increase in cumulus expansion was observed in bovine
COCs matured in vitro with concentrations of PGE2 over
50 ng/ml but only in the presence of serum. In the absence
of serum, there was little cumulus expansion of bovine
COCs with 500 ng/ml PGE2. Rat COCs failed to expand
with 352 ng/ml PGE2 in the presence of fetal bovine serum
[37], but the same PGE2 concentration induced cumulus
expansion in the presence of granulosa cells [2]. It is pos-
sible that incompatibility between serum and factors pro-
duced by the expanding cumuli of different species could
affect response to PGE2, as it has been reported that the
composition of serum IaIs differ among species [38, 39].
It is not known what the granulosa contributes to cumulus
expansion in vivo; however, the bovine COCs employed in
these experiments were not cocultured with granulosa cells
during in vitro maturation.
In rats, COX-2 protein was induced in preovulatory fol-
licles only by hCG, not by FSH or E2 treatments [8].
COX-2 protein and mRNA expression increased in preovu-
latory bovine granulosa cells in vivo by 16–24 h after hCG
or the endogenous LH surge [10, 11, 22, 36]. COX-2 im-
munoreactivity increased 79-fold in granulosa cells at 24 h
compared to 0 h of estrus [36], while the mRNA was re-
ported to increase 3000-fold in the same time period [22].
In addition, COX-2 mRNA expression increased in bovine
granulosa cells cultured with serum or hCG [22]. It has not
often been reported whether COX-2 is also expressed in
cumulus cells; however, one study reported intense COX-2
immunoreactivity in mouse cumulus as well as in mural
granulosa 8 h after hCG [9]. This is the first instance in
which COX-2 mRNA was reported to be expressed in bo-
vine COCs. In the current experiment, COX-2 mRNA was
detected by RT-PCR in bovine COCs at 0 h, prior to place-
ment in maturation culture. Expression increased in all
quality grades at 6–12 h of maturation, then decreased from
18 to 24 h (Fig. 3). In a previous study, the cumulus was
reported to exhibit expansion in vivo prior to detection of
COX-2 protein in the bovine follicle [10]. Because
COX-2 mRNA was detected in bovine cumulus prior to
expansion (this study) but is not detected in granulosa until
after cumulus expansion [10], it is possible that COX-2 has
two temporally distinct functions in bovine preovulatory
follicles, the first being production of PGE2 in the cumulus
for expansion, and the second, to induce follicular rupture.
Recently, three groups have produced targeted gene de-
letions of the mouse PGE receptor 2 (EP2). Two strains
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have decreased ovulation rates [19, 21], and all three strains
have severely impaired fertilization [19–21]. One mouse
strain demonstrated defects in cumulus expansion [19],
while another mouse strain was reported to be normal in
this respect [20]. The severity of the EP2 phenotype may
depend on the genetic background of the mice, as two
strains also differed in blood pressure [20, 21]. It is thought
that other EPs may potentially compensate for the lack of
EP2 function in null mice [19, 20]. In the mouse strain with
the most severe cumulus defect, the COCs failed to expand
in vitro when cultured with PGE2, although expansion was
normal in response to gonadotropins [19]. Of the PGE2 re-
ceptors, it was suspected that EP2 would have the most
important role in the bovine ovary. The present experiments
are the first to report expression of the EP2 receptor mRNA
in bovine COCs. EP2 mRNA was detectable by RT-PCR
from 0 to 24 h of maturation in bovine COCs, and there
were no differences in expression among oocyte qualities.
Although in mouse cumulus, EP2 mRNA expression in-
creased following hCG [19], in bovine COCs there was a
tendency toward decreased EP2 mRNA expression over
maturation time.
In a recent paper, EP3 mRNA was detected at very low
copy number in granulosa of preovulatory bovine follicles
collected prior to the LH surge [22] and did not increase
in granulosa cells of preovulatory follicles 24 h after an
induced LH surge. However, expression of EP3 mRNA in-
creased following in vitro culture of granulosa cells in me-
dia containing serum for 24 h [22]. This is the first time
that EP3 mRNA has been reported to be present in bovine
COCs. The EP3 sequence is not reported here, as it was
100% identical to the bovine EP3 sequence reported in
Genbank. In the current experiments, expression of EP3
mRNA was detected in bovine COCs at 0 h. EP3 mRNA
expression increased at 6 h, then remained at a fairly con-
stant level throughout the culture period. EP3 mRNA was
more highly expressed in COCs of the better quality grades;
however, it is unclear whether increased EP3 expression is
related to increased developmental competence of these oo-
cytes. Perhaps the association of increased expression with
increased COC quality was more evident with EP3 than
EP2 and COX-2 mRNAs due to the lower variability of
EP3 among replicates. The function of EP3 in COCs and
corpora lutea is not clear, as mouse knockouts of EP3 do
not display any obvious reproductive impairments [40], and
expression of EP3 mRNA is higher in adrenal, myometri-
um, and heart tissue than in corpora lutea [23]. Possibly,
increased expression of EP3 in COCs or granulosa is re-
lated to luteinization. Although EP4 mRNA is expressed at
very low levels in bovine COCs, it is unlikely to be essen-
tial for reproduction, as surviving mouse EP4 knockouts
were able to reproduce [41, 42]. Thus far, we have been
unable to detect EP1 in bovine COCs but EP1 seems to be
the PGE2 receptor most restricted in expression and has
only been detected in mouse kidney, lung, and hypothala-
mus [43, 44].
Several mRNAs such as COX-2 [10], LHr [45], and 3b-
hydroxysteroid dehydrogenase [46] are not detectable in
granulosa until bovine follicles reach at least 8–9 mm or
potentially preovulatory in size. However, bovine COCs are
commonly collected from follicles 2–8 mm in size for in
vitro procedures. Oocytes from smaller follicles have a low-
er development rate than those from larger follicles [28,
47], and oocytes matured in vitro have lower developmental
rates than ovulated oocytes [48, 49]. Little is known about
gene expression in preovulatory COCs; therefore, it is not
known whether current bovine in vitro maturation proce-
dures induce equivalent mRNA expression (timing and
amount) as in vivo-matured COCs. COCs collected from
follicles maturing in vivo at various times from the LH
surge would be the best controls to examine gene expres-
sion, but these would be difficult and expensive to collect.
It is feasible to study how advancements in maturation con-
ditions that improve development rate (gas atmosphere,
hormones, growth factors, etc.) affect gene expression dur-
ing maturation and culture in vitro.
Because COX-2 mRNA and protein are expressed in ma-
turing COCs, and PGE2 is detected in follicular fluid and
culture media, it is likely the PGE2 pathway is involved in
oocyte maturation and cumulus expansion in vivo. As well,
defects in cumulus expansion and fertilization in EP2
knockout mice suggest that this is an important pathway
for female reproduction in vivo. However, it may not be as
critical to achieve optimal cumulus expansion in vitro be-
cause the oocyte does not need to escape from the follicle.
In addition, sperm numbers may be high enough to achieve
satisfactory fertilization in vitro, whereas the lower sperm
numbers in vivo require that the cumulus be sufficiently
expanded to achieve optimal fertilization rates.
Despite many years of research, even the best maturation
and oocyte culture systems result in the development in
vitro of only 30–35% oocytes to the blastocyst stage [24,
25], which is substantially lower than the in vivo devel-
opmental rate. It is necessary to define marker genes that
predict developmental competence of oocytes and embryos
in vitro and in vivo and that would allow design of more
appropriate maturation and culture media. This study is the
first to examine expression of COX-2 and prostaglandin
receptor mRNAs in bovine COCs and underscores that ex-
pression of these mRNAs is dependent on time of matu-
ration and oocyte quality. The differential expression of the
EP3 mRNA among varying COC qualities indicates that
this gene product may be a useful marker to predict embryo
development.
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